EvolVeritas Biotechnology

EvolVeritas Ltd. is a spinoff biotech company founded by scientists studying the molecular mechanism of complement activation through structure-driven protein engineering, directed protein evolution and enzymology.

Our Vision

To become a significant player in generating research tool ligands for discovering new drug targets and for developing drug candidate compounds through the development of specific protein molecules. We bring breakthroughs in therapeutic areas such as ischemic reperfusion injury, thrombosis, and COVID-19.

Our Mission

Pick-up and further develop therapeutically promising results of academic discoveries, which opens new avenues for the treatment of serious diseases with high unmet medical need.

 

Our Goals

To maximally explore the therapeutic opportunities of our existing patents by addressing as many therapeutic areas as possible. Developing additional novel human protein based drug candidates in therapeutic areas with high unmet medical need.

Our Strengths & Capabilities

Experience

189 cumulative years of experience in pharmaceutical R&D

Research

15+ years research on the complement lectin pathway and MASP-2

Evolution

Over 50 proteins evolved

Business Development

30+ years experience in business development

Contracts

Contracts with Eötvös Loránd University and Eötvös Loránd Research Centre

Publications

130+ publications of the founders

Patents

3 patents

Partnerships

Multinational pharma partners: Bayer, Gedeon Richter

Office Locations

Budapest

Corvin stny. 1/b. 9. em. 6.
H-1082

Szentes

Somogyi Béla u. 17.
H-6600